Recurrent Endometrial Cancer: Which Is the Best Treatment? Systematic Review of the Literature
Background: Endometrial cancer is the most common gynaecological tumour in developed countries. The overall rate of relapse has remained unchanged in recent decades. Recurrences occur in approximately 20% of endometrioid and 50% of non-endometrioid cases. The aim of this systematic review is to comp...
Main Authors: | Stefano Restaino, Giorgia Dinoi, Eleonora La Fera, Benedetta Gui, Serena Cappuccio, Maura Campitelli, Giuseppe Vizzielli, Giovanni Scambia, Francesco Fanfani |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-08-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/14/17/4176 |
Similar Items
-
Therapeutic approaches in patients with bone metastasis due to endometrial carcinoma – A systematic review
by: Martin Heidinger, et al.
Published: (2023-08-01) -
The use of neoadjuvant chemotherapy in advanced endometrial cancer
by: L. Philp, et al.
Published: (2021-05-01) -
Management of inoperable endometrial cancer
by: Supakorn Pitakkarnkul, et al.
Published: (2022-07-01) -
Endometrial stromal sarcoma: Retrospective analysis of a tertiary care experience from India
by: Rajit Rattan, et al.
Published: (2020-01-01) -
Patterns of Disease Relapses in Patients with High-risk Endometrial Carcinoma Following Concurrent Chemoradiation with Paclitaxel
by: Osama M. Abd El-Badee, et al.
Published: (2023-01-01)